Volume | 3,353,969 |
|
|||||
News | (1) | ||||||
Day High | 118.41 | Low High |
|||||
Day Low | 116.02 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Agilent Technologies | A | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
117.77 | 116.02 | 118.41 | 118.22 | 116.26 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
41,707 | 3,353,969 | $ 117.53 | $ 394,189,059 | - | 112.52 - 160.265 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:05:32 | 1 | $ 118.85 | USD |
Agilent Technologies Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 34.92B | 295.38M | 294.59M | $ 1.72B | $ 3.09M | 1.19 | 29.60 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ 0.23 | 0.77% | 06/30/23 | 18.47k | 0.10% |
Agilent Technologies News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical A Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 120.12 | 121.305 | 114.795 | 117.03 | 3,037,250 | -1.90 | -1.58% |
1 Month | 135.30 | 135.57 | 113.2801 | 123.70 | 2,361,147 | -17.08 | -12.62% |
3 Months | 140.42 | 141.48 | 113.2801 | 130.55 | 1,811,256 | -22.20 | -15.81% |
6 Months | 153.97 | 160.265 | 113.2801 | 139.16 | 1,522,226 | -35.75 | -23.22% |
1 Year | 122.77 | 160.265 | 112.52 | 135.02 | 1,484,917 | -4.55 | -3.71% |
3 Years | 90.00 | 179.57 | 83.71 | 131.42 | 1,613,737 | 28.22 | 31.36% |
5 Years | 63.17 | 179.57 | 60.42 | 103.72 | 1,841,442 | 55.05 | 87.15% |
Agilent Technologies Description
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations. |